14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 42 days ( -32.74 % )
Last Price $1.00 0 %
High/ Low $1.00 - $1.00 0%
Chg 7 Days N/A $1.00 $1.00
Chg 30 Days 13.12 % $0.88 $1.00
Chg 12 mos -15.65 % $1.18 $1.00
Trend - 3 mos 52.76 % Width: 20.16 %
Trend - 12 mos -27.41 % Width: 147.21 %
Pred. range - 3 mos $1.48 - $1.78 48.59 % - 78.55 %
Pred. range - 12 mos $0.306 - $0.756 -69.29 % - -24.07 %
Short MA avg 3 mos Sell Apr 05, 2024 - 14 days
Long MA avg 3 mos Buy Feb 23, 2024 - 43 days
Short/Long MA avg 3 mos Buy Feb 26, 2024 - 42 days
Short MA avg 12 mos Buy Mar 21, 2024 - 24 days
Long MA avg 12 mos Buy Feb 22, 2024 - 44 days
Short/Long MA avg 12 mos Sell Feb 21, 2024 - 45 days
Pivot Short Sell Mar 28, 2024 - 19 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Onconova Therapeutics

Onconova Therapeutics Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in combination with other anti-cancer therapies; and oral rigosertib alone or in combination with P... ONTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT